Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Annelies de Hondt"'
Autor:
Johan van Griensven, Saskia van Henten, Aderajew Kibret, Mekibib Kassa, Hailemariam Beyene, Saïd Abdellati, Dagnew Mersha, Kasaye Sisay, Hailemicheal Seyum, Hamid Eshetie, Fikadu Kassa, Tadfe Bogale, Roma Melkamu, Arega Yeshanew, Bart Smekens, Christophe Burm, Hanne Landuyt, Annelies de Hondt, Dorien Van den Bossche, Rezika Mohammed, Myrthe Pareyn, Florian Vogt, Wim Adriaensen, Koert Ritmeijer, Ermias Diro
Publikováno v:
EBioMedicine, Vol 110, Iss , Pp 105474- (2024)
Summary: Background: Targeted preventive strategies in persons living with HIV (PLWH) require markers to predict visceral leishmaniasis (VL). We conducted a longitudinal study in a HIV-cohort in VL-endemic North-West Ethiopia to 1) describe the patte
Externí odkaz:
https://doaj.org/article/948699d033844540b4f37d2a8d62ca1a
Autor:
Emmanuel Bottieau, Achilleas Tsoumanis, Yven Van Herrewege, Diana Arango, Christophe Burm, Badara Cisse, Souleymane Mboup, Clémentine Roucher, Isabel Brosius, Moustapha Mbow, Babacar Thiendella Faye, Annelies De Hondt, Bart Smekens, Linda Paredis, Idzi Potters, Katja Polman
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
Introduction Alternative drugs and diagnostics are needed for the treatment and control of schistosomiasis. The exclusive use of praziquantel (PZQ) in mass drug administration programmes may result in the emergence of drug resistance. PZQ has little
Externí odkaz:
https://doaj.org/article/3da4c2cc84e141b5b33081c8df3a5e81
Autor:
Eric Florence, Jolein Laumen, Achilleas Tsoumanis, Chris Kenyon, Annelies De Hondt, Christophe Van Dijck, Vicky Cuylaerts, Irith De Baetselier, Yven Van Herrewege
Publikováno v:
Sexually transmitted diseases
This single-arm open-label pilot trial in Antwerp, Belgium, was ended early in accordance with the protocol because twice-daily gargling with chlorhexidine 0.2% for 6 days failed to eradicate Neisseria gonorrhoeae from the oropharynx of asymptomatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c36572e175bcec65444c21894dd0491e
https://hdl.handle.net/10067/1854800151162165141
https://hdl.handle.net/10067/1854800151162165141
Autor:
Idzi Potters, Bart Smekens, Diana Arango, Katja Polman, Linda Paredis, Emmanuel Bottieau, Annelies De Hondt, Clémentine Roucher, Christophe Burm, Badara Cisse, Souleymane Mboup, Moustapha Mbow, Yven Van Herrewege, Isabel Brosius, Babacar Faye, Achilleas Tsoumanis
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
BMJ Open, 11(6):e047147. BMJ Publishing Group
BMJ Open
Roucher, C, Brosius, I, Mbow, M, Faye, B T, De Hondt, A, Smekens, B, Arango, D, Burm, C, Tsoumanis, A, Paredis, L, Van Herrewege, Y, Potters, I, Cisse, B, Mboup, S, Polman, K & Bottieau, E 2021, ' Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM) : Protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial ', BMJ Open, vol. 11, no. 6, e047147 . https://doi.org/10.1136/bmjopen-2020-047147
BMJ Open, 11(6):e047147. BMJ Publishing Group
BMJ Open
Roucher, C, Brosius, I, Mbow, M, Faye, B T, De Hondt, A, Smekens, B, Arango, D, Burm, C, Tsoumanis, A, Paredis, L, Van Herrewege, Y, Potters, I, Cisse, B, Mboup, S, Polman, K & Bottieau, E 2021, ' Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM) : Protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial ', BMJ Open, vol. 11, no. 6, e047147 . https://doi.org/10.1136/bmjopen-2020-047147
IntroductionAlternative drugs and diagnostics are needed for the treatment and control of schistosomiasis. The exclusive use of praziquantel (PZQ) in mass drug administration programmes may result in the emergence of drug resistance. PZQ has little a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb9981179aced8bbe014e423c9c69f5b
https://bmjopen.bmj.com/content/11/6/e047147.full
https://bmjopen.bmj.com/content/11/6/e047147.full
Autor:
Dennis Belmans, Cedric Van Holsbeke, Glenn Leemans, Annelies De Hondt, Kris Ides, Brian Becker, Kim Van Hoorenbeeck
Publikováno v:
Cystic fibrosis.
Introduction: High frequency chest wall oscillation (HFCWO) is a commonly used airway clearance technique (ACT) in patients with Cystic Fibrosis (CF). However, the usability of an HFCWO device is dependent on an AC power source. This study aimed to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b9af6ec1572853acce874562fda75bd
https://doi.org/10.1183/13993003.congress-2019.pa4528
https://doi.org/10.1183/13993003.congress-2019.pa4528